🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Kambiz Yazdi

Stock Analyst at BTIG

(2.50)
# 3,052
Out of 5,162 analysts
93
Total ratings
40.6%
Success rate
2.1%
Average return

Stocks Rated by Kambiz Yazdi

Zevra Therapeutics
Nov 19, 2026
Maintained: Buy
Price Target: $24 → $21
Current: $11.17
Upside: +88.00%
Sionna Therapeutics
Nov 11, 2026
Maintained: Hold
Price Target: n/a
Current: $3.73
Upside: -
Praxis Precision Medicines
Nov 10, 2026
Maintained: Buy
Price Target: $826
Current: $284.79
Upside: +190.04%
Kazia Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $40
Current: $8.08
Upside: +395.05%
vTv Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $57
Current: $24.03
Upside: +137.20%
Absci
Oct 6, 2026
Reiterated: Buy
Price Target: $16
Current: $10.48
Upside: +52.67%
Rapport Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $75
Current: $25.93
Upside: +189.24%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €66.85
Upside: +81.00%
Arcutis Biotherapeutics
Jan 15, 2026
Reiterated: Buy
Price Target: $31
Current: $34.05
Upside: -8.96%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $47.38
Upside: n/a
Initiated Coverage: Buy
Price Target: $23
Current: $7.07
Upside: n/a
Reiterated: Buy
Price Target: $15
Current: $0.395
Upside: n/a
Initiated Coverage: Buy
Price Target: $5
Current: $1.33
Upside: n/a
Reiterated: Buy
Price Target: $15 → $14
Current: $1.09
Upside: n/a
Upgraded: Buy
Price Target: $7
Current: $0.0005
Upside: n/a